Literature DB >> 22366095

Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients.

Tracy Ann Williams1, Silvia Monticone, Riccardo Urbanet, Chiara Bertello, Giuseppe Giraudo, Roberto Vettor, Francesco Fallo, Franco Veglio, Paolo Mulatero.   

Abstract

Primary aldosteronism (PA) patients display an increased incidence of insulin resistance. Herein we demonstrate the decreased gene expression of lipid metabolism genes PCK1, PLIN, ADIPOQ and PPARG in the visceral adipose tissue (VAT) of PA patients compared to age-, sex- and BMI-matched controls. In VAT, the expression of PCK1, PLIN, ADIPOQ and PPARG was inversely correlated with aldosterone levels; furthermore, PLIN and ADIPOQ gene expression was correlated with potassium levels. Therefore, raised aldosterone and low potassium may contribute to the reduced expression of these genes in PA patients. Finally, incubation of primary cultures of human adipocytes with aldosterone resulted in a decrease in the expression of PCK1, PLIN and ADIPOQ and this effect was blocked by eplerenone. Therefore, the characteristic aldosterone excess of PA patients may mediate the down-regulation of PCK1, PLIN and ADIPOQ in VAT that in turn may contribute to the insulin resistance observed in PA patients. Copyright Â
© 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366095     DOI: 10.1016/j.mce.2012.02.007

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

Review 1.  Aldosterone Production and Signaling Dysregulation in Obesity.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

Review 2.  Aldosterone excess and resistant hypertension: investigation and treatment.

Authors:  Michael Stowasser
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 3.  Genomic and rapid effects of aldosterone: what we know and do not know thus far.

Authors:  Milla Marques Hermidorff; Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

Review 4.  Effects of aldosterone on insulin sensitivity and secretion.

Authors:  James M Luther
Journal:  Steroids       Date:  2014-09-04       Impact factor: 2.668

5.  Effects of Primary Aldosteronism and Different Therapeutic Modalities on Glucose Metabolism.

Authors:  Mi Kyung Kwak; Jee Yang Lee; Beom-Jun Kim; Seung Hun Lee; Jung-Min Koh
Journal:  J Clin Med       Date:  2019-12-12       Impact factor: 4.241

Review 6.  Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism.

Authors:  Xiao Lin; Muhammad Hasnain Ehsan Ullah; Xiong Wu; Feng Xu; Su-Kang Shan; Li-Min Lei; Ling-Qing Yuan; Jun Liu
Journal:  Front Cardiovasc Med       Date:  2022-02-02

7.  Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.

Authors:  Silvia Lai; Luigi Petramala; Daniela Mastroluca; Emanuela Petraglia; Alessandro Di Gaeta; Elena Indino; Valeria Panebianco; Mauro Ciccariello; Hossein H Shahabadi; Alessandro Galani; Claudio Letizia; Anna Rita D'Angelo
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.